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The human immunodeficiency virus type 1 (HIV-1) virion contains two copies of genomic RNA that are noncovalently
attached along a region at their 5 ends, in which two contact sites have been observed by electron microscopy. One of these
sites is believed to be the stem-loop 1 (SL1) sequence which serves as the dimerization initiation site (DIS), and the other
site, closer to the 5 end of the viral RNA, may involve the R or U5 RNA sequences. In this study, we present biochemical
evidence showing that alteration of the U5 RNA sequence in the context of full-length viral RNA leads to diminished
dimerization of virion RNA. In particular, two stretches of GU-rich sequences, which are located at nucleotides (nt) 99 to 108
and nt 112 to 123 within U5, were either deleted or substituted with exogenous sequences. The mutated viruses thus
generated all exhibited deficient RNA dimerization. This dimerization deficit was not corrected by second-site mutations that
preserved local RNA structures, such as the poly(A) hairpin, and was overcome to only a limited extent by compensatory
mutations within Gag; these mutations were identified after long-term culture of the relevant mutant viruses in permissive cell
lines and were able to restore viral infectiousness and RNA packaging to wild-type levels. Therefore, these GU sequences
do not regulate RNA dimerization by the formation of local secondary structures nor by the maintenance of efficient viral RNA
packaging; instead, they may mediate direct RNA–RNA interactions in the dimer structure. In contrast, mutation of
palindrome 5-AAGCUU-3, which resides within R and crowns the poly(A) hairpin, did not affect either RNA dimerization orINTRODUCTION
All retroviruses possess diploid RNA genomes that are
noncovalently dimerized in a parallel orientation near
their 5 ends (Bender and Davidson, 1976; Kung et al.,
1976; Bender et al., 1978; Murti et al., 1981). This diploid
status is believed to increase the rate of genetic recom-
bination (Hu and Temin, 1990) and to contribute to overall
genetic diversity (Goodenow et al., 1989; Wain-Hobson,
1992; Coffin, 1996). The dimer linkage site (DLS) of hu-
man immunodeficiency virus (HIV-1) was originally
mapped to a region downstream of the 5 major splice
donor (SD) site that partially overlaps the gag coding
region (Darlix et al., 1990). Existence of purine-rich se-
quences in this DLS suggests the formation of purine
quartet structures during RNA dimerization (Marquet et
al., 1991; Baudin et al., 1993; Sundquist and Heaphy,
1993). Subsequently, it was discovered that HIV-1 RNA
sequences located upstream of the 5 SD site can form
dimers in cell-free assays without the assistance of the
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152originally defined DLS element (Marquet et al., 1994). In
this RNA fragment, a stem-loop structure, termed SL1,
which is located between the primer binding site and the
5 SD site, was shown to be indispensable for the dimer-
ization process (Laughrea and Jette, 1994; Paillart et al.,
1994; Skripkin et al., 1994). The palindromic nature of the
SL1 loop sequence (5-GCGCGC-3 in HXB2) led to a
kissing-loop model to explain the mechanisms involved
in the initiation of dimerization; SL1 was thereafter
termed the dimerization initiation site (DIS) (Paillart et al.,
1996). This hypothesis has been supported by results
from both in vitro and in vivo studies (Clever et al., 1996;
Haddrick et al., 1996; Laughrea and Jette, 1996a,b, 1997;
Paillart et al., 1996, 1997; Clever and Parslow, 1997;
Laughrea et al., 1997, 1999; Shen et al., 2000).
However, the understanding of HIV-1 RNA dimerization
has been complicated by the finding that significant
amounts of dimerized viral genomic RNA can be found in
mutant viruses that contain severe disruptions of the DIS
structure; this implies the involvement of other viral RNA
sequences in the dimerization process (Berkhout and
van Wamel, 1996; Sakuragi and Panganiban, 1997). Also,
a recent electron microscopy (EM) study of HIV-1
genomic RNA revealed two linkage sites at the 5 ends ofRNA packaging. © 2002 Elsevier Science (USA)
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dimerized RNA molecules (Hoglund et al., 1997). One of
these two linkage sites can be attributed to the DIS; DIS;
sequence, whereas the other one, closer to the 5 end of
the viral RNA, may involve the R or U5 RNA sequences.
Conceivably, even though disruptions of the DIS struc-
ture eliminate one linkage site, the other may persist and
thus still stabilize RNA dimers to a certain extent.
Sequence analysis reveals two types of RNA se-
quences within R and U5 that may participate in dimer-
ization. One of these consists of two segments of GU-
rich sequences that are located at nucleotides (nt) 99 to
108 and nt 112 to 123 in U5 (Fig. 1A). Since G and U can
form base pairs, it follows that these GU-rich RNA se-
quences may bind to their counterparts in a second RNA
molecule and, therefore, contribute to the stabilization of
RNA dimers. The other sequence is a 5-AAGCUU-3
palindrome that is located at nt 77 to 82 (Fig. 2A). Since
this palindrome is positioned at the top of the poly(A)
hairpin (Fig. 2A), a feature that resembles the DIS struc-
ture, we speculate that it may also play a role in RNA
dimerization via a kissing-loop mechanism similar to that
of the DIS.
To assess the roles of the aforementioned RNA se-
quences in RNA dimerization, we mutated these RNA
sequences in the context of a full-length viral genome
and measured their effects on the conformation of virion-
associated genomic RNA by performing native Northern
blots. Our results revealed that the GU-rich sequences
within U5, but not the 5-AAGCUU-3 palindrome in the R
region, were needed for efficient RNA dimerization.
RESULTS
Deletions of the GU-rich sequences in the HIV-1 U5
region cause deficient viral RNA dimerization
and packaging
Two stretches of GU-rich sequences are located at nt
99 to 108 and nt 112 to 123 within the U5 region (Fig. 1A).
We assessed the roles of these RNA sequences in RNA
dimerization by deletion of nt 99 to 108 in construct GU2
and deletion of nt 112 to 123 in construct GU3. To study
the potential synergistic effects of these two RNA
stretches, both sequences were deleted to produce the
GU2-3 construct (Fig. 1A). When these mutant viral DNA
and wild-type BH10 were transfected into COS-7 cells,
the mutant viruses generated showed only minor effects
in the processing of Gag proteins compared to the wild
type, as demonstrated by the results of Western blots
performed either with cell lysates or with virus particles
(Fig. 1B). Next, we used denaturing Northern blots to
examine the viral RNA species expressed upon transfec-
tion of these mutant DNA constructs into COS-7 cells.
Three major viral RNA bands were observed for all of the
DNA constructs tested; these represented full-length
(9.2K nt) and spliced (4K and 2K nt) viral RNAs (Fig. 1C).
Of the three mutant constructs, GU2 and GU2-3 ex-
hibited moderate reductions in the overall quantities of
viral RNA (Fig. 1C).
The infectiousness of mutant viruses was then exam-
ined by the infection of MT-2 cells with an amount of
virus containing 3 ng of p24 antigen. In comparison to the
wild-type virus, the GU3 deletion delayed viral replica-
tion by approximately 8 days. High levels of viral repli-
cation were not seen with the GU2 mutant virus until
the end of the fourth week in culture, whereas infectious
virus was never recovered with the GU2-3 mutation
(Fig. 1D). Therefore, the GU2 deletion caused a more
severe deficit in viral replication than did GU3, and both
deletions together virtually eliminated viral infectious-
ness.
To investigate the effects of these deletion mutations
on viral RNA dimerization, viral RNA was extracted from
each of the GU2, GU3, and GU2-3 mutant viruses
under mild conditions and fractionated on native agarose
gels, followed by Northern blot analysis. The results
shown in Fig. 1E demonstrate that the BH10 wild-type
virus contained mainly the dimeric form of viral RNA. In
contrast, each of the mutated viruses displayed predom-
inantly the monomeric form of viral RNA. The relative
percentages of dimer versus monomer for each mutant
are summarized in the bar graph on the right of this
figure. Also observed was that the GU2 and GU2-3
mutated viruses exhibited weak RNA signals due to low
overall levels of viral RNA packaging. To clearly visualize
the viral RNA bands associated with these two mutant
viruses, additional analysis was performed with in-
creased amounts of viral RNA, and these results con-
firmed that the GU2 and GU2-3 mutant viruses con-
tained mainly monomeric RNA (Fig. 1E, bottom). To verify
the dimer versus monomer features of the observed RNA
bands, RNA samples prepared from either GU3 or
BH10 viruses were first treated at various temperatures
before being separated on native agarose gels. In the
case of BH10, RNA dimers dissociated at 50oC and
migrated as monomers on the gels (Fig. 1F). Similarly, the
weak dimer bands associated with GU3 disappeared at
high temperatures and migrated as monomers (Fig. 1F).
Taken together, we conclude that these GU sequences
are needed for efficient viral RNA dimerization.
Also noticeable is that these three deletion mutations
exhibited lower levels of viral RNA (including both the
dimeric and monomeric forms) than the wild-type BH10,
with GU2 and GU2-3 showing the most adverse ef-
fects (Fig. 1E, top). Since both the mutant and the wild-
type RNA were prepared from virus particles that con-
tained 300 ng of p24, it follows that these GU-rich se-
quences, especially those located at nt 99 to 108, are
apparently involved in RNA packaging. This conclusion
was further supported by the results of reverse transcrip-
tion (RT)–PCR (Fig. 1G). A fragment of gag RNA was
amplified to measure the quantities of full-length viral
RNA prepared from either mutant or wild-type virus par-
ticles. Consistent with the observations made with the
native Northern blots (Fig. 1E), GU2 and GU2-3
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caused significant reductions in RNA packaging, where-
as GU3 alone showed a modest defect in this regard
(Fig. 1G).
A second-site mutation can correct deficient RNA
packaging, but not the diminished dimerization,
caused by mutations of the GU sequence
(nt 99 to 108)
Next, we selectively mutated part of the GU sequence
(nt 99 to 108) and generated construct AS4, in which the
nt sequences 5-AAGUAGUG-3 (nt 97 to 104) were
changed to 5-UCCAUCAU-3 (Fig. 2A). This AS4 mutant
virus exhibited severe defects in both RNA dimerization
and packaging (Fig. 2B), concurrent with significantly
attenuated infectivity in permissive cells (Fig. 2C).
Since these GU sequences (nt 99 to 108) constitute
part of the poly(A) hairpin (Fig. 2A), an RNA structure that
has been shown to participate in RNA packaging (Das et
al., 1997; McBride et al., 1997; Clever et al., 1999), it is
possible that the AS4 mutation exerted its effects on RNA
dimerization and packaging by disrupting this RNA struc-
ture. Indeed, the results of RNA secondary structure
modeling based on the M-Fold program (Matthews et al.,
1999; Zuker et al., 1999) revealed a negative impact of
AS4 on the poly(A) structure (Fig. 2A). To further evaluate
the sequence versus structural effects of the AS4 muta-
tion, a second-site mutation AS5 was designed and fur-
ther recombined with AS4 in order to restore the poly(A)
stem (Fig. 2A). The resultant structures were predicted
on the basis of the M-Fold program (Matthews et al.,
1999; Zuker et al., 1999) and are shown in Fig. 2A.
The AS5 mutation alone caused moderate defects in
viral RNA packaging and dimerization (Fig. 2B). Recom-
bination of AS4 and AS5 in AS45 led to wild-type lev-
els of RNA packaging in contrast to severely deficient
dimerization. Consistent with the elevated RNA packag-
ing, AS45 mutant viruses showed increased infectious-
ness compared with AS4 (Fig. 2C). Therefore, deficient
RNA dimerization caused by mutations of the GU
sequence (nt 99 to 108) persisted in the face of wild-type
RNA packaging restored by a second-site mutation
that preserves the poly(A) RNA structure. These results
suggest that the GU sequences studied are directly
involved in RNA–RNA interactions within the dimer struc-
ture.
The palindrome residing on the top of the poly(A)
hairpin does not contribute to RNA dimerization
Next, we deleted part of the loop sequence at nt 73 to
78 in construct (A) to determine whether the palin-
drome 5-AAGCUU-3 (nt 77 to 82), which crowns the 5
poly(A) hairpin, is able to regulate dimerization via a
kissing-loop mechanism, as does the DIS motif (Fig. 2A).
It is important to note here that no mutations were made
in the 3 poly(A) region; thus, the polyadenylation of viral
RNA transcripts would not be affected in any of these
mutants, since the 5 poly(A) is silenced (Berkhout et al.,
1995; Graveley et al., 1996; Das et al., 1997, 1999; Klas-
sens et al., 1998, 1999). The results illustrated in Fig. 2B
show that the (A) mutant virus contained wild-type
levels of dimeric RNA. Consistently, the (A) deletion had
no apparent effect on viral replication (Fig. 2C), as would
be expected, since this mutation would quickly revert to
the wild-type sequence during reverse transcription due
to its position in R. Based on these results, we believe
that the loop sequence of the poly(A) hairpin is not
involved in viral RNA dimerization.
FIG. 1. Various effects of two stretches of GU-rich sequences, located within the U5 region, on viral gene expression, viral replication, and viral RNA
packaging and dimerization. (A) Illustration of the GU sequences and their locations within U5. The sequences at nt 99 to 108 and nt 112 to 123 were
deleted in constructs GU2 and GU3, respectively. Both nucleotide stretches were eliminated in GU2-3. (B) Viral protein analysis by Western blots
using antibodies against p24 (CA). Western blots were performed either with cell lysates from transfected COS-7 cells or with lysed virus particles
harvested from culture fluids by ultracentrifugation. (C) Viral RNA analysis by denaturing Northern blots. Transfected COS-7 cells were first lysed in
NP-40 lysis buffer. RNA was extracted from cell lysates using phenol/chloroform/isoamylalcohol and then subjected to denaturing Northern blots. To
rule out possible saturation of the hybridization signals, two dilutions for each RNA sample (1:1 (lanes 1 to 5) and 1:3 (lanes 6 to 10)) were loaded
on the gels. RNA was prepared from mock-transfected COS-7 cells and also used in the hybridization experiments to serve as negative controls. Three
major RNA bands were seen that represent full-length (9.2K nt) and spliced (4K and 2K nt) viral RNA species. Ribosomal RNAs (28S and 18S) were
visualized by staining the agarose gels with EtBr; the signals served as internal controls for RNA integrity and to ensure that the same amounts of
total cellular RNA had been loaded for each construct. (D) Infectiousness of the mutant and wild-type viruses in MT-2 cells. Progeny viruses generated
by transfected COS-7 cells were used to infect MT-2 cells. Viral growth was monitored by measuring RT activities in the culture fluids at various time
points. (E) Analysis of viral RNA within virus particles by native Northern blots. Viral RNA for each construct was prepared from virus particles
containing 300 ng of p24 (CA) under mild conditions (in the presence of 100 mM NaCl) and then fractionated on native agarose gels before being
subjected to Northern blotting. Positions of RNA dimers and monomers are labeled on the left sides of the gels. The proportion of each RNA form
in each construct was measured using the NIH Image program and plotted. The data shown are calculated from one representative experiment. RNA
levels in wild-type BH10 were arbitrarily set at 100. In order to clearly visualize the two RNA forms in the mutant viruses, higher amounts of RNA
samples were loaded on the gels, and the results are shown in the bottom gel. (F) Thermostability of RNA dimers. Virion RNA was first treated at
various temperatures (40o, 45o, 50o, and 55oC) for 10 min in the presence of 100 mM NaCl before being separated on agarose gels. (G) Measurement
of full-length viral RNA by semiquantitative RT–PCR. Three dilutions of virion RNA for each construct were used in RT–PCR (1:1 (lane 1), 1:3 (lane 2),
and 1:9 (lane 3)). RNase A-treated RNA samples were amplified by RT–PCR to serve as negative controls (lane 4). Proviral DNA representing 101, 102,
103, and 104 copies of HIV were subjected to RT–PCR to demonstrate the linear range of the reactions.
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The T12I (in p2) and V13G (in NC) point mutations
restore the replication capacity of GU3 but not of
GU2 to that of nearly wild-type levels
The GU3 mutated virus was able to produce high
levels of viral RT activity and cause syncytium formation
after 15 days, indicating that rapid viral replication had
occurred (Fig. 1D). The GU2 mutated virus yielded in-
fectious virus after 28 days (Fig. 1D). In contrast, GU2-3
failed to replicate over 60 days after a single infection
event (data not shown). Viruses derived from the GU2
and GU3 infections were further used to infect fresh
MT-2 cells over multiple infection cycles until wild-type
replication kinetics had been established. Proviral DNA
FIG. 2. Substitutions of the poly(A) stem or loop sequences and their effects on viral infectivity and viral RNA dimerization. (A) Illustration of the (A),
AS4, AS5, and AS45 mutations. The (A) mutation lacks the RNA sequence 5-AAUAAA-3 at nt 73 to 78. The bottom stem structure of the poly(A)
hairpin was destabilized by mutations AS4 and AS5 and restored in construct AS45. The modified sequences in mutations AS4, AS5, and AS45 are
highlighted. The given structures and the relevant G values (kcal/mol) were predicted by the M-Fold program (Matthews et al., 1999; Zuker et al.,
1999). (B) Effects of these mutations on viral RNA dimerization and packaging as determined by native Northern blots. Viral RNA was prepared from
virus particles containing 300 ng of p24 antigen. Intensities of RNA signals were measured using the NIH Image program and data from one
representative experiment are shown. RNA levels from wild-type BH10 were arbitrarily set at 100. (C) Replication kinetics of the AS4, AS5, AS45, or
(A) mutant viruses. Virus growth in MT-2 cells was monitored by measuring RT activity in culture fluids at various times.
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was then extracted from the infected MT-2 cells and
assessed by PCR, cloning, and sequencing. We found
that the GU3 deletion had been sustained during this
time, while the viral sequences that had been deleted in
GU2 had been restored.
In order to identify any second-site mutations that
might have conferred wild-type replication kinetics to
GU3, the 5 noncoding leader sequences and the gag-
coding region of GU3 proviral DNA were sequenced.
Two point mutations were identified, i.e., a T12I substi-
tution in p2 and a V13G substitution in NC (Fig. 3A).
These two substitutions were then recombined either
separately or together with the GU3 deletion to test
whether they were sufficient to rescue the defect caused
by this mutation. The results detailed in Fig. 3B show that
V13G only slightly increased the infectivity of GU3,
while T12I markedly stimulated viral replication. When
both of these mutations were present (GU3-T12I-V13G),
replication kinetics close to wild-type levels were ob-
served (Fig. 3B). Therefore, both T12I and V13G play key
roles in the rescue of the GU3 mutant virus.
Since the sequences that were deleted in GU2 and
GU3 were similar, we wished to know whether the T12I
and V13G substitutions, identified in GU3, could also
rescue GU2. Toward this end, these two point muta-
tions were inserted into GU2, and the progeny viruses
that were recovered after transfection with these recom-
binant constructs were used to infect fresh MT-2 cells.
The results presented in Fig. 3C show that no viral
infectiousness resulted from this step. Based on these
results, we conclude that T12I and V13G were unable to
rescue GU2 and thus that the location of the deleted
sequence within GU2 as opposed to GU3 may be of
critical importance in this regard. In addition, the results
of infectivity studies showed that neither V13G nor T12I
alone, or in combination, compromised the replication
capacity of the wild-type BH10 (Fig. 3C).
The T12I and V13G mutations compensate for defective
RNA packaging caused by the GU3 deletion
Next, we measured the levels of dimeric RNA in the
recombinant viruses GU3-T12I, GU3-V13G, and GU3-
T12I-V13G by native Northern blots. In comparison with
the GU3 construct, GU3-T12I displayed slightly higher
levels of dimeric viral RNA (Fig. 3D). In the case of
GU3-V13G and GU3-T12I-V13G, marked increases in
the amounts of dimers were observed; however, these
were still lower than that of wild-type virus (Fig. 3D). It
was also found that the GU3-T12I-V13G recombinant
virus contained wild-type levels of total viral RNA (includ-
ing both dimeric and monomeric forms) (Fig. 3D). There-
fore, the compensatory mutations T12I and V13G were
able to improve viral RNA dimerization in GU3 to higher
levels, which, together with the restored RNA packaging,
may account for the increased infectivity of the GU3
revertants.
DISCUSSION
EM observation of two tightly associated retroviral
RNA molecules in diverse types of retroviruses repre-
sents visual evidence for the existence of viral RNA
dimers (Kung et al., 1975, 1976; Bender and Davidson,
1976; Dube et al., 1976; Bender et al., 1978; Maisel et al.,
1978; Murti et al., 1981; Stokrova et al., 1982). The region
of RNA involved in dimerization commonly displays an
X-like structure in EM, indicating a single contact site
present between the two RNA molecules. In contrast,
when the conformation of HIV-1 genomic RNA was stud-
ied by EM, the 5 regions of the two linked viral RNA
molecules were found to display a ring-like structure
(Hoglund et al., 1997), suggesting two contact points
between the RNA strands. One of these is thought to be
facilitated by the DIS, while the other may involve the R
and U5 sequences. Our studies now provide in vivo
biochemical evidence supporting the participation of U5
RNA sequences in HIV-1 RNA dimerization.
In this study, we have focused on the potential dimer-
ization roles of two stretches of GU-rich sequences lo-
cated within the U5 region. Since the G and U bases can
form hydrogen bonds and thus contribute to interactions
between RNA strands, we hypothesize that GU se-
quences in U5 may assist in the stabilization of RNA
dimer structures. Indeed, either deletions (i.e., GU2,
GU3, and GU2-3) or substitutions (i.e., AS4) of these
GU sequences impaired RNA dimerization.
In order to understand the mechanisms by which
these GU sequences affect RNA dimerization, two issues
need to be clarified. First, since these GU sequences,
especially the one located at nt 99 to 108, are believed to
participate in complex RNA folding, one can speculate
that mutation of these GU sequences may have dis-
rupted the relevant RNA structures and, as a conse-
quence, indirectly compromised RNA dimerization. If
RNA structures, rather than RNA sequences, play major
roles in RNA packaging and dimerization, then preser-
vation of these structures with exogenous sequences
should ensure efficient RNA packaging and dimerization.
However, when the disrupted poly(A) structure caused
by the AS4 mutation was restored by a second-site
mutation, i.e., AS5, the impairment in dimerization per-
sisted, even though RNA packaging was restored to that
of wild-type levels (Fig. 2B). Hence, it appears that the
GU sequences (nt 99 to 108), which were changed in the
AS4 mutation, exert their effects on dimerization in a
sequence-specific manner. We are now in the process of
establishing an in vitro dimerization system to further
analyze the contribution of these GU sequences to the
process of HIV-1 RNA dimerization. Another interesting
possibility is that these GU sequences may actually be
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NC binding sites, as previously shown for other GU-rich
sequences (Berglund et al., 1997). If so, our mutations
might indirectly affect dimerization through some mech-
anism of reduced NC-mediated activation of dimerization
or dimer maturation. This possibility is currently under
investigation, although it’s confirmation is doubtful, since
the dimers contained within the mutant viruses are as
thermostable as that of the wild type (Fig. 1F).
The second issue concerns the potential mutual influ-
ences of RNA packaging and dimerization. Diminished
FIG. 3. Compensation of the GU3 deletion by second-site mutations in Gag. (A) Illustration of the second-site mutations found in p2 (T12I) and
NC (V13G). The mutated amino acids are underlined. The protease cleavage site between p2 and NC is indicated by an arrow. (B) Rescue of the GU3
mutated viruses by the T12I and V13G mutations. T12I and V13G were recombined with the GU3 deletion to generate constructs GU3-T12I,
GU3-V13G, and GU3-T12I-V13G. MT-2 cells were infected with relevant recombinant viruses, and RT activity in the culture fluids was measured at
various times to monitor virus growth. (C) Effects of the T12I and V13G mutations on infectiousness of GU2 and wild-type viruses. (D) Effectiveness
of the T12I and V13G compensatory mutations in correcting the defective RNA dimerization and packaging associated with the GU3 deletion. Viral
RNA was extracted from virus particles containing 300 ng of p24 antigen and then analyzed by native Northern blots. RNA signals were measured
using the NIH Image program and relative levels of viral RNA associated with each construct were plotted. RNA levels in wild-type BH10 were
arbitrarily set at 100. Data shown are from one representative experiment.
158 RUSSELL ET AL.
RNA packaging was repeatedly observed together with
impaired dimerization in various mutant viruses that har-
bored mutated GU sequences. It is thus reasonable to
postulate that the mutated GU sequences actually
caused deficient RNA packaging, which subsequently
led to impaired dimerization, possibly due to insufficient
amounts of viral RNA within virus particles. If this is the
case, then the GU sequences contribute to dimerization
merely in an indirect manner. However, opposing evi-
dence argues against this hypothesis. The first clue
comes from the AS45 mutation, in which a second-site
mutation, i.e., AS5, restored RNA packaging in the con-
text of the AS4 mutation to that of wild-type levels but
failed to correct deficient RNA dimerization caused by
AS4. These findings are similar to those reported in a
recent article in which the authors describe HIV-1 mu-
tants with defects in dimerization but displaying RNA
encapsidation ability comparable to that of wild-type
particles (Sakuragi et al., 2002). Second, compensatory
mutations T12I (in p2) and V13G (in NC) increased the
GU3 RNA packaging to that of wild-type levels, but had
a limited effect on the diminished levels of RNA dimers
associated with mutant viruses. Although the mecha-
nism by which these compensatory mutations contribute
to the increase in packaging is unclear at this time, we
may gain some insight if we consider the interactions
between HIV-1 NC and SL3. Solution structure analysis
of NC complexed with SL3 RNA predicts that the V13
residue of NC is actually in contact with the viral RNA (De
Guzman et al., 1998). The authors report that nt G9 of the
SL3 loop interacts with the FI knuckle (F1-V13 to A30) of
NC by binding to a hydrophobic cleft formed by the side
chains of V13, F16, I24, and A25. Based on these obser-
vations, we propose that the substitution of the bulky
methyl groups, associated with the Val residue for the
hydrogen associated with the Gly residue of our V13G
mutation, might reduce the extent of steric interaction in
the cleft and allow the RNA to bind more tightly, thus
contributing to the increased packaging seen in these
mutants. Also of interest is that other groups have re-
ported similar results indicating a role for this region of
NC in the encapsidation process. In one study, mutation
of positions 10 and 11 in NC, adjacent to the V13 men-
tioned above, decreased genomic RNA packaging levels,
indicating the importance of this region for genome rec-
ognition and encapsidation (Cimarelli et al., 2000). The
location of our T12I compensatory mutation in the p2
domain of Gag and its putative effect on genome pack-
aging are also in agreement with previous findings sug-
gesting a possible role for p2 in RNA encapsidation
(Kaye and Lever, 1998; Rong et al., 2001). In another
study, RNA packaging defects, but not dimerization def-
icits, caused by elimination of a portion of the DIS se-
quences were corrected by compensatory mutations
within Gag (Shen et al., 2000). This latter observation
indicates that the role played by DIS RNA in the dimer-
ization process cannot be performed by modified Gag
proteins. Conceivably, the failure of the T12I and V13G
compensatory mutations to correct deficient RNA dimer-
ization associated with the GU3 deletion suggests a
possible direct participation of this GU-rich fragment in
RNA dimerization.
The ability of the GU2 mutated viruses to reestablish
wild-type sequences may be due to the fact that the
GU2 deletion is present only in the U5 region at the 5
end of proviral DNA. Although the 3 U5 region is nor-
mally removed at the termination stage of transcription,
transcriptional error can occasionally result in retention
of wild-type U5 sequences at the 3 end of viral RNA.
During reverse transcription, the first strand transfer is
usually directed by the binding of full-length minus ()-
strand strong-stop cDNA to 3 R sequences (Skalka and
Goff, 1993). However, premature reverse transcription
that occurs before nt 110 in U5 (Fig. 1) may result in a
premature cDNA product being able to mediate the first
strand transfer if a U5 is still available at the 3 end of the
viral RNA. Reverse transcription could then continue
from the transferred cDNA to copy the wild-type 3 U5
sequences. Previous studies that employed natural
tRNALys.3 as primer and synthetic viral RNA templates
identified a strong pause site around nt 111 (Liang et al.,
1997). Such pausing may also occur during in vivo re-
verse transcription and help GU2 recapture lost se-
quences via this mechanism.
These two GU-rich RNA stretches within U5 each
contain a 5-UGUGUG-3 element with a palindromic
feature (Fig. 1A). It is postulated that the 5-UGUGUG-3
sequences can pair with their counterparts on a second
RNA strand to mediate dimerization. Although the G:U
pairing may be less stable than that of G:C, the existence
of two stretches of 5-UGUGUG-3 within U5 may over-
come any diminution in pairing stability. And, further-
more, viral protein factors such as the NC protein may
further stabilize these interactions. GU sequences may
act either to trigger dimerization together with the DIS or
to stabilize dimers that are already formed. Detailed
genetic analysis will be required to sort out these pos-
sibilities.
We also confirmed that a 5-AAGCUU-3 palindrome,
located within the loop of the 5–poly(A) hairpin, did not
contribute to RNA dimerization (Laughrea et al., 2001).
This failure may be due to certain structural features of
this palindrome. Compared to the 5-GCGCGC-3 palin-
drome within the DIS, 5-AAGCUU-3 contains only one
G and one C. Since G and C form a stronger base pair
than that formed by A and U, it follows that interactions
between RNA strands mediated by the 5-AAGCUU-3
would be weaker than those mediated by the 5-
GCGCGC-3. Therefore, the former palindrome may not
be able to initiate RNA interactions that are strong
enough to trigger RNA dimerization. Moreover, structural
studies reveal that the A residues within the DIS loop
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significantly contribute to the stability of RNA dimers, in
addition to the role played by the 5-GCGCGC-3 palin-
drome (Mujeeb et al., 1998, 1999; Ennifar et al., 2001).
Hence, specific structural features distinct from the pal-
indrome sequence are needed for an RNA motif to serve
as a dimerization initiation site.
In conclusion, we propose that the GU sequences
studied above are involved in the process of HIV-1 RNA
dimerization, although this region does not necessarily
constitute a new “dimerization initiation site.” Rather,
these sequences may function to stabilize the RNA dimer
after the known DIS has started the process. This notion
is compatible with previous reports suggesting that the
dimerized RNA are bound together by direct RNA–RNA
linkages along the entire genome (Ortiz-Conde and
Hughes, 1999). In other dimer linkages, such as those
seen in Harvey sarcoma virus (Feng et al., 1995), Molo-
ney murine sarcoma virus (Ly et al., 1999), and rat retro-
transposon VL30 (Torent et al., 1994a,b), the involvement
of multiple regions in the dimerization process has been
reported. It has also been reported that the Moloney
murine leukemia virus contains dual DIS elements, both
of which participate in the initiation of dimerization.
(Oroudjev et al., 1999; Ly and Parslow, 2002). The authors
further hypothesize that the idea of multiple adjacent
regions being involved in dimer linkages may prove to be
a common theme among retroviruses. In line with this
notion, we propose that the dimerization of the HIV-1




The BH10 infectious HIV-1 cDNA clone was used as
starting material for mutagenesis studies. The GU2 and
GU3 deletions lack viral sequences at nt 99 to 108 and
nt 112 to 123, respectively (Fig. 1A). The nucleotide po-
sitions refer to the first nt of the 5 R region. These two
deletions were further recombined to generate construct
GU2-3. GU2 was engineered by PCR using primer
pair pGU2 [5-GCCTTGAGTGCTTCAACCCGTCTGTTGT-
GTGACTCTGG-3 (nt 83 to 130)]/pA [5-CCATCGATCTA-
ATTCTCCC-3 (383 to 365)]. The PCR product was used
as a primer in a second round of PCR together with
primer pHpa-S [5-CTGCAGTTAACTGGAAG GGCTAAT-
TCACTCCC-3 (nt 454 to 433)]. The final product was
digested with restriction enzymes Hpa I and BssHII and
inserted into BH10 to generate GU2. GU3 and GU2-3
were generated with a similar strategy through the use of
primers pGU3 [5-GCTTCAAGTAGTGTGTGCCCACTCT-
GGTAACTAGAGATC-3 (nt 92 to 142)] and pGU2-3 [5-
GCCTTGAGTGCTTCAACCCACTCTGGTAACTAGAGATC-
3 (nt 83 to 142)], respectively.
Constructs AS4 and AS5 contain substituted se-
quences at nt 97 to 104 and nt 58 to 65, respectively (Fig.
2A). (A) lacks the RNA sequence 5-AAUAAA-3 at nt 73
to 78 (Fig. 2A). These constructs, respectively, were en-
gineered by PCR using primers pAS4 [5-CTTGAGTGCT-
TCTCCATCATTGTGCCCGTCTGT-3 (nt 85 to 117)], pAS5
[5-CAAGCTTTATTGAGGCTTTCCATCATGGTTCCCTAGTT-
AGCC-3 (nt 83 to 42)], and p(A) [5-CCCACTGCTTAAGC-
CTCGCTTGCCTTGAGTGCTTC-3 (nt 56 to 96)].
The T12I point mutation was generated as previously
described (Fig. 3A) (Liang et al., 1998). The V13G substi-
tution in the NC protein (Fig. 3A) was constructed by PCR
using primer pair pV13G [5-CCAAAGAAAGATTGGTA-
AGTGTTTCAATTG-3 (nt 1490 to 1519)]/pAPA-A [5-
CCTAGGGGCCCTGCAATTTCTG-3 (nt 1562 to 1541)].
This PCR product was used as a primer in a second
round of PCR together with primer pSph-S [5-AGTG-
CATCCAGTGCATGCAGGGCC-3 (nt 977 to 1000)]. The
final PCR product was digested with ApaI and SphI and
inserted into BH10, GU2, or GU3. All primers were
purchased from Invitrogen (Burlington, Ontario, Canada).
Cell culture, transfection, and infection
COS-7 and MT-2 cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) and RPMI 1640, re-
spectively, supplemented with 10% fetal calf serum.
Transfection of COS-7 cells was performed with Lipo-
fectamine (Invitrogen). Progeny viruses were harvested
48 h after transfection and the quantities of viruses were
determined by measuring the levels of p24 (CA) antigen
by enzyme-linked immunosorption assays (Vironostika
HIV-1 Antigen Microelisa System, Organon Teknika
Corp., Durham, NC).
Amounts of virus equivalent to 3 ng of p24 were used
to infect 3  105 MT-2 cells. Cells were washed twice at
2 h after infection and cultured in complete RPMI 1640.
Reverse transcriptase activity in culture fluids was mea-
sured at various times to monitor viral growth.
Analysis of viral proteins by Western blots
The culture fluids from transfected COS-7 cells were
first clarified at 3000 rpm in a Beckman GS-6R benchtop
centrifuge at 4°C for 30 min. Progeny viruses were then
pelleted through a 20% sucrose cushion using a SW41
rotor in an L8-M ultracentrifuge at 40,000 rpm for 1 h at
4°C. The virus pellet was suspended in NP-40 lysis
buffer (Sambrook et al., 1989). The transfected COS-7
cells were washed twice with cold phosphate-buffered
saline and scraped from the plates. The cells were then
lysed in NP-40 lysis buffer. Both virus and cell lysates
were fractionated on sodium dodecyl sulfate (SDS)–12%
polyacrylamide gels and proteins were transferred onto
a PVDF membrane (Roche Inc., Laval, Quebec, Canada).
Viral proteins were detected using IgG monoclonal anti-
bodies against HIV-1 p24 (CA) antigen (ID Labs Inc.,
London, Ontario, Canada).
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Analysis of viral RNA by Northern blots and RT–PCR
To prepare sufficient amounts of viral RNA from virus
particles for native Northern blots, approximately 60 ml of
culture supernatants from transfected COS-7 cells was
collected and spun in 70-ml tubes at 35,000 rpm for 1 h
at 4°C using a Ti45 rotor in a Beckman L8-M ultracen-
trifuge. Virus pellets were suspended in 10 ml of DMEM
and spun through a 20% sucrose cushion in TN buffer at
40,000 rpm for 1 h at 4°C using a SW41 rotor. Virus
pellets were resuspended in 300 l of TN buffer, a 2-l
portion was removed for p24 determination, and the
remaining virions were disrupted using a 4 lysis buffer
[final concentrations of 50 mM Tris–Cl (pH 7.4), 10 mM
EDTA, 1% SDS, 100 mM NaCl] as previously described
(Fu et al., 1994). Samples were digested with proteinase
K (100 g/ml) in the presence of yeast tRNA (100 g/ml)
(Invitrogen) for 20 min at 37°C and then extracted twice
with an equal volume of phenol/chloroform/isoamylalco-
hol (25:24:1) (Invitrogen) and once with chloroform. The
RNA was precipitated in 2.5 vol of 95% ethanol and a 0.1
vol of 3 M sodium acetate (pH 5.2). RNA pellets were
washed with 70% ethanol and dissolved in TE buffer.
Native Northern blots were performed as follows. An
amount of viral RNA equivalent to 300 ng of p24 was
separated on 0.9% agarose gels at 100 V in 1 TBE
buffer for 4 h at 4°C. RNA was transferred to a nylon
membrane (Amersham Pharmacia Biotech., Montreal,
Quebec, Canada) and baked at 80°C for 2 h. The mem-
branes were prehybridized for 3 h at 42°C in a hybrid-
ization buffer containing 6 SSPE (pH 7.4), 50% form-
amide, 0.5% SDS, 5 Denhardt’s, and 80 g/ml herring
sperm DNA (Invitrogen). A 2-kb HIV-1 DNA fragment at nt
1 to 2000 was nick-labeled with [32P-]dCTP (ICN, Irvine,
CA) and used as a probe. After prehybridization, the
membranes were hybridized with 1.5  106 cpm (400 ng
DNA) of probe for 18 h. Membranes were washed for 10
min at room temperature and then at 65°C, with each of
2, 1, and 0.2 SSPE, 0.1% SDS and exposed to X-ray
films.
To determine the thermostability of virion-derived RNA,
RNA samples were first treated at different temperatures
(i.e., 40o, 45o, 50o, and 55oC) for 10 min in the presence of
100 mM NaCl before being fractionated on 0.9% agarose
gels.
An amount of progeny virus equivalent to 10 ng of p24
was used to prepare viral RNA using the QIAamp Viral
RNA Mini Kit (Qiagen, Mississauga, Ontario, Canada).
Viral RNA from viruses containing 0.2 ng of p24 was first
treated with 20 units of RNase-free DNase I (Invitrogen)
to remove any possible DNA contamination and was
then subjected to RT–PCR (Titan One-Tube RT–PCR Sys-
tem, Roche Inc.) using primer pair pGAG1/pST-A (Liang
et al., 1998). The RT–PCR products were fractionated on
5% native polyacrylamide gels and visualized by expo-
sure to X-ray films.
Cellular RNA was studied by denaturing Northern
blots as follows. The transfected COS-7 cells were
washed twice with cold phosphate-buffered saline and
lysed with NP-40 lysis buffer. The cell lysates were di-
gested with proteinase K (100 g/ml) for 20 min at 37°C,
and RNA was extracted as described above. A 1% de-
naturing agarose gel containing 1 MOPS buffer and
18% formaldehyde was prepared as described (Sam-
brook et al., 1989). RNA samples were denatured by
heating in the presence of formamide and formaldehyde,
loaded onto the gels, and run at 100 V for 4 h. After
electrophoresis, the gel was rinsed in distilled water and
RNA was transferred onto nylon membranes. Prehybrid-
ization and hybridization were performed as described
above. Similar amounts of RNA were also run on a 1%
agarose gel and stained with ethidium bromide (EtBr) in
order to visualize 28S and 18S ribosomal RNAs.
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